Bhanu K. Sadasivan, Ph.D.

McDermott Will & Emery

Articles

Results 1 to 5 of 16
Most popular |Most recent


Court’s Drug Patent Prescription: Unclaimed Disclosure is Dedicated

USA - May 19 2020 Addressing the disclosure-dedication doctrine, the US Court of Appeals for the Federal Circuit concluded that the disclosure-dedication doctrine…

No Concrete Controversy If There are No Claims

USA - September 27 2019 In reversing a district court decision as to whether a validity issue remained justiciable after the challenged claims were disclaimed, the US Court…

Nothing Exceptional About Litigation Costs Exceeding Potential Damages

USA - September 27 2019 Addressing the issue of whether litigation costs that exceed potential damages necessarily render a case exceptional, the US Court of Appeals for the…

Case Law Beats PTO Guidance on Patent Eligibility

USA - May 30 2019 A panel of the US Court of Appeals for the Federal Circuit found claims directed to methods of identifying and detecting a biomarker to be directed to…

A Special “Treatment” for Patent Eligibility

USA - April 30 2019 Addressing the patentability of method-of-treatment claims, the US Court of Appeals for the Federal Circuit issued two decision finding such claims…